Company profile
Gradalis company profile
Gradalis is a late stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil, our proprietary immunotherapy platform in multiple advanced cancer indications with the lead program for the treatment of patients with Ewing's sarcoma.
Business identity
- Website
- http://www.gradalisinc.com
- Contact email
- [email protected]
- Phone number
- 214-442-8100
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2003-01-01, Year
Headquarters
- Headquarters
- Sand Springs, Oklahoma, United States
- Postal code
- 75006
- Country code
- US
- Continent
- North America